MARKET

VALN

VALN

Valneva Se
NASDAQ
6.38
-0.07
-1.09%
Closed 16:10 05/13 EDT
OPEN
6.43
PREV CLOSE
6.45
HIGH
6.43
LOW
6.18
VOLUME
5.96K
TURNOVER
--
52 WEEK HIGH
9.50
52 WEEK LOW
3.620
MARKET CAP
518.05M
P/E (TTM)
-23.4559
1D
5D
1M
3M
1Y
5Y
1D
US Health Agencies Recommend Pausing Valneva's Chikungunya Vaccine For Older Adults After Adverse Events
Benzinga · 1d ago
Valneva’s Chikungunya Vaccine Use Paused for Elderly Amid Safety Review
TipRanks · 1d ago
Weekly Report: what happened at VALN last week (0505-0509)?
Weekly Report · 2d ago
Valneva's IXCHIQ Use In Elderly Paused By FDA And CDC Amid Ongoing Review Of Serious Adverse Events
Benzinga · 2d ago
BRIEF-FDA And CDC Recommend Pause In Use Of Valneva's Chikungunya Vaccine In Elderly
Reuters · 2d ago
Valneva: FDA Recommends Pause In Use Of IXCHIQ Vaccine In Elderly Individuals
NASDAQ · 2d ago
VALNEVA SE - FDA AND CDC RECOMMEND PAUSE IN USE OF VALNEVA'S CHIKUNGUNYA VACCINE IN ELDERLY
Reuters · 2d ago
U.S. recommends a pause in Valneva chikungunya vaccine for those over 60
Seeking Alpha · 3d ago
More
About VALN
More
Valneva SE is a France-based company that specializes in the development, manufacture and commercialization of vaccines to protect people from infectious diseases through preventative medicine. The Company's portfolio includes two commercial vaccines for travelers: IXIARO/JESPECT, for the prevention of Japanese Encephalitis, and DUKORAL, which is indicated for the prevention of cholera and, in some countries, prevention of diarrhea caused by Enterotoxigenic escherichia coli (ETEC). The Company has also vaccines in development, including candidates against Lyme disease, COVID-19 and chikungunya. Its technologies and services segment cooperates with various pharmaceutical companies using its platform: EB66 vaccine production cell line and IC31 adjuvant. The Company is focused on research and development (R&D) programs, as well as holds investment in product candidates and commercial products.
Recently
Symbol
Price
%Change

Webull offers Valneva SE (ADR) stock information, including NASDAQ: VALN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VALN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VALN stock methods without spending real money on the virtual paper trading platform.